title: Interference of rivaroxaban in one-stage and chromogenic factor VIII:C assays.
authors: V
authors: V
authors: Tichelaar
authors: H
authors: H
authors: de Jong
authors: H
authors: H
authors: Nijland
authors: H
authors: H
authors: Kluin-Nelemans
authors: K
authors: K
authors: Meijer
authors: A
authors: A
authors: Mulder
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D015415:Biomarkers / Q000097:blood; D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests; D004305:Dose-Response Relationship, Drug; D005169:Factor VIII / Q000032:analysis*; D065427:Factor Xa Inhibitors; D006801:Humans; D009025:Morpholines / Q000008:administration & dosage / Q000009:adverse effects*; D009426:Netherlands; D010314:Partial Thromboplastin Time; D011237:Predictive Value of Tests; D011517:Prothrombin Time; D000069552:Rivaroxaban; D013876:Thiophenes / Q000008:administration & dosage / Q000009:adverse effects*; D013997:Time Factors; D020246:Venous Thrombosis / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy*
chemical_list: D000925:Anticoagulants; D015415:Biomarkers; D065427:Factor Xa Inhibitors; D009025:Morpholines; D013876:Thiophenes; D005169:Factor VIII; D000069552:Rivaroxaban